SABER Issues Warning on the Public Health Risks of Synthetic 7-OH

Published

2025-04-17

min read

Overview

‍

Read Here

‍

From groundbreaking research findings and industry advancements to policy changes and public health initiatives, we cover the stories that matter most.

Subscribe to our newsletter.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Continue reading

PUBLIC HEALTH

The rise of novel, semi-synthetic 7-hydroxymitragynine products

Novel semi-synthetic 7-hydroxymitragynine products pose public health risks due to the unknown chemical constituents and the known pharmacology of 7-hydroxymitragynine.

NEWS

Tulane School of Medicine Offers First-of-Its-Kind Accredited CME on Kratom

Tulane University School of Medicine is proud to announce a groundbreaking CME program focused on the emerging research and clinical challenges surrounding kratom use. This live activity has been approved for AMA PRA Category 1 Credit™, equipping healthcare professionals with essential knowledge from leading experts.

EVENTS

Fourth International Kratom Symposium

The Fourth International Kratom Symposium is an invitation only event that will bring together the world’s most preeminent scholars on Mitragyna speciosa from across disciplines including botany, chemistry, pharmacology, toxicology, clinical study and population health and health policy.